The Swedish mutation (K595N/M596L) of amyloid precursor protein (APP-swe) has been known to increase abnormal cleavage of cellular APP by Beta-secretase (BACE), which causes tau protein hyperphosphorylation and early-onset Alzheimer's disease (AD). Here, we analyzed the effect of APP-swe in global gene expression using deep transcriptome sequencing technique. We found 283 genes were down-regulated and 348 genes were up-regulated in APP-swe expressing H4-swe cells compared to H4 wild-type cells from a total of approximately 74 million reads of 38 base pairs from each transcriptome. Two independent mechanisms such as kinase and phosphatase signaling cascades leading hyperphosphorylation of tau protein were regulated by the expression of APP-swe. Expressions of catalytic subunit as well as several regulatory subunits of protein phosphatases 2A were decreased. In contrast, expressions of tau-phosphorylating glycogen synthase kinase 3β (GSK-3β), cyclin dependent kinase 5 (CDK5), and cAMP-dependent protein kinase A (PKA) catalytic subunit were increased. Moreover, the expression of AD-related Aquaporin 1 and presenilin 2 expression was regulated by APP-swe. Taken 
INTRODUCTION
The development of gene expression microarrays in the mid 1990s represented a significant technical achievement that permitted the systematic genome-wide evaluation of gene expression (1, 2). The ability of microarrays has led to important advances in a wide range of biological problems, including the identification of gene expression differences among diseased and healthy tissues, and new insights into developmental processes pharmacological responses, and of the evolution of gene regulation (3-6). Nonetheless, array technology has several limitations. For example, background levels of hybridization (i.e., hybridization to a probe that occurs irrespective of the corresponding transcript's expression level) limit the accuracy of expression measurements, particularly for transcripts present in low abundance. Furthermore, probes differ considerably in their hybridization properties (7).
Deep transcriptome sequencing (RNA-Seq) has recently emerged as a method enabling the study of RNA-based regulatory mechanisms in a genome-wide manner (8). RNA-Seq overcomes several shortcomings of microarray-based detection of transcripts, including probe cross-hybridization (9), restricted signal dynamic range, and low sensitivity and specificity, which often lead to difficulties in the detection of low abundance transcripts and discrimination between similar sequences. Sequence level transcript information has much greater power to distinguish between paralogous genes, better detection of low abundance transcripts, and allows replicable digital quantification based upon counting sequence reads (10-14). Furthermore, RNA-Seq can identify transcript sequence polymorphisms, RNA editing sites, and splicing variants, and there is no strict requirement for a reference genome sequence (15).
Alzheimer's disease (AD) is characterized by memory impairment caused by extracellular senile plaques, intracellular neurofibrillary tangles, and neuronal death. There have been extensive reports that the pathogenesis of this disease is closely related to abnormal proteolytic cleavage of amyloid precursor protein (APP), which leads to deposits of insoluble Aβ aggregates.
Recently, it has been reported that the APP intracellular domain (AICD) moves to nucleus and regulates transcriptional transactivation (16, 17) . The nuclear localization of AICD was proposed to be interacting with adapter protein Fe65 and his-http://bmbreports.org BMB reports Total base mapped to 25,627 known Refseq. Genes tone acetyl transferase Tip60. Several target genes of this transcriptional modulation include glycogen synthase kinase-3 beta, CD82, and APP (18-21). APP also controls aquaporin 1 gene expression by epigenetic control mechanism (22). The Swedish mutation of APP, replacement of Lys-595 and Met-596 with Asp and Lys respectively, enhances early-onset and propagation of AD, and leads to the cognitive impairments associated with AD (23).
In this study, we investigated the role of APP-swe mutation in the pathogenesis of AD with regard to transcriptional regulation using deep transcriptome sequencing technique. We demonstrated that the exogenous expression of APP-swe modulated global gene expression including AD-related phosphatases, kinases, presenilin2, and glycogen synthase kinase 3β.
RESULTS

Transcriptome analysis of H4 cell line expressing APP-swe mutant
We investigated the transcriptomes of wild-type H4 and H4-swe cells by sequencing at a depth of roughly 74 million short reads per sample. Gene expression was estimated by calculating read density as 'reads per kilobase of exon model per million mapped reads' (RPKM). These estimates are typically performed using common gene annotation (e.g., RefSeq) with the entire annotated transcript representing the 'exon model'. To identify the APP-swe-regulated genes, we compared the number of reads mapped to transcripts. In each sample, approximately 20,000 known RefSeq genes were detected by one or more reads (Table 1) . Many of the 20,000 mRNAs in each sample were represented by only a few reads. We observed an estimated 15,000 genes at a threshold of 20 reads per gene. We determined that the expression of 283 up-regulated and 348 down-regulated genes differed significantly between the control and APP-swe-transfected cells with the criteria of a fold change greater than 2 and transcript number larger than 3. Genes which were up-regulated by greater than 4-fold (Supplementary Table 1A ) or down-regulated by greater than 7-fold (Supplementary Table 1B) in APP-swe-transfected cell compared with control cells were presented. The stable cell line expressing APP-swe mutant showed 1.5-fold increase in APP transcript compared to wild type cells expressing wild-type APP.
Gene Ontology (GO) analysis
We used the PANTHER (www.pantherdb.org) to categorize the up-and down-regulated genes identified in the current study. We performed GO analysis with expressed genes whose expression was up-and down-regulated by greater than 2-fold change in APP-swe-transfected H4 cells compared with wild-type H4 control cells.
Gene Ontology analysis revealed that genes involved in synthase and synthetase and nucleic acid binding were specifically enriched in the up-regulation category (Supplementary
